ArticleJournal of surgical case reports2026
Hybrid surgical approach for chronic pancreatitis: pyloric-ring-resection pancreaticoduodenectomy with lateral pancreatojejunostomy.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreaticoduodenectomy (PD) and lateral pancreatojejunostomy are established surgical techniques for treating chronic pancreatitis (CP), but their combination has not been studied. We performed PD combined with lateral pancreatojejunostomy in 15 patients with morphological changes consistent with CP. Preoperative imaging revealed features of CP confined to the head of the pancreas (HOP) and main pancreatic duct (MPD) dilation with strictures and stones in all but one patient. Surgical procedures were completed successfully in all the patients. One patient (6.6%) developed major complications that required reoperation. There was no 90-day mortality. At follow-up (median, 66 months), pain, quality of life, and exocrine function had improved, whereas endocrine function worsened in 4 of the 7 non-insulin-dependent diabetic patients, requiring insulin therapy. This hybrid approach provided durable pain relief, improved quality of life, and stabilized exocrine function. Endocrine deterioration in some cases highlights the challenges of managing pre-existing pancreatic insufficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.